Skip to main content
Top
Published in: Heart and Vessels 2/2020

01-02-2020 | Arterial Diseases | Original Article

Clinical impact of improvement in the ankle–brachial index after endovascular therapy for peripheral arterial disease

Authors: Tomonori Katsuki, Kyohei Yamaji, Yusuke Tomoi, Seiichi Hiramori, Yoshimitsu Soga, Kenji Ando

Published in: Heart and Vessels | Issue 2/2020

Login to get access

Abstract

Predictive ability of changes in the ankle–brachial index (ABI) after revascularization for long-term clinical outcomes remains unclear. Pre- and postprocedural ABI were recorded for 1307 consecutive patients who underwent their first successful EVT for symptomatic aortoiliac (n = 710) or femoropopliteal (n = 597) lesions. The patients were divided into two groups according to the increase in ABI: ∆ABI ≥ 0.15 (n = 980) and ∆ABI < 0.15 (n = 327). We investigated the association between ABI improvement after EVT and long-term clinical outcomes. The clinical outcome measures included all-cause mortality, myocardial infarction, stroke, target limb revascularization, EVT for target lesion revascularization, major amputation of the target limb, and a composite endpoint that included both target limb revascularization and major amputation. All-cause mortality was significantly lower in the ∆ABI ≥ 0.15 group than in the ∆ABI < 0.15 group [crude hazard ratio (HR) 0.77, 95% confidence interval (CI) 0.60–0.98, P = 0.03]; however, this was no longer statistically significant after adjusting for baseline characteristics (adjusted HR 0.82, 95% CI 0.63–1.07, P = 0.14). A composite of target limb revascularization and major amputation was less often observed at 10 years in the ΔABI ≥ 0.15 group (258 patients, 38%) compared with the ΔABI < 0.15 group (112 patients, 59%; adjusted HR 0.54, 95% CI 0.42–0.68, P < 0.001), mainly because of a lower risk of target limb revascularization (adjusted HR 0.54, 95% CI 0.42–0.69, P < 0.001). No significant interactions were noted with regard to the locations of the treated lesions (P for the interaction, 0.13) or preprocedural ABI (P for the interaction, 0.40). An increase of ABI ≥ 0.15 after successful EVT was an independent predictor for freedom from a composite of target limb revascularization and major amputation, irrespective of the locations of the treated lesions and the preprocedural ABI.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fakhry F, Spronk S, van der Laan L, Wever JJ, Teijink JAW, Hoffmann WH, Smits TM, van Brussel JP, Stultiens GNM, Derom A, den Hoed PT, Ho GH, van Dijk LC, Verhofstad N, Orsini M, van Petersen A, Woltman K, Hulst I, van Sambeek MRHM, Rizopoulos D, Rouwet EV, Hunink MGM (2015) Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA 314:1936–1944CrossRef Fakhry F, Spronk S, van der Laan L, Wever JJ, Teijink JAW, Hoffmann WH, Smits TM, van Brussel JP, Stultiens GNM, Derom A, den Hoed PT, Ho GH, van Dijk LC, Verhofstad N, Orsini M, van Petersen A, Woltman K, Hulst I, van Sambeek MRHM, Rizopoulos D, Rouwet EV, Hunink MGM (2015) Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA 314:1936–1944CrossRef
2.
go back to reference Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UKA, Williams LJ, Mensah GA, Criqui MH (2013) Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382:1329–1340CrossRef Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UKA, Williams LJ, Mensah GA, Criqui MH (2013) Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382:1329–1340CrossRef
3.
go back to reference Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FGR, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RAG, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME (2017) 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation 135:e726–e779PubMed Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FGR, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RAG, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME (2017) 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation 135:e726–e779PubMed
4.
go back to reference Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, TASC II Working Group (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45(Suppl S):S5–67CrossRef Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, TASC II Working Group (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45(Suppl S):S5–67CrossRef
5.
go back to reference US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Tseng C-W, Wong JB (2018) Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index: US preventive services task force recommendation statement. JAMA 320:177–183CrossRef US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Tseng C-W, Wong JB (2018) Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index: US preventive services task force recommendation statement. JAMA 320:177–183CrossRef
6.
go back to reference Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, Darius H, Burghaus I, Trampisch HJ, German Epidemiological Trial on Ankle Brachial Index Study Group (2009) Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 120:2053–2061CrossRef Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, Darius H, Burghaus I, Trampisch HJ, German Epidemiological Trial on Ankle Brachial Index Study Group (2009) Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 120:2053–2061CrossRef
7.
go back to reference Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV (2004) Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 109:733–739CrossRef Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV (2004) Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 109:733–739CrossRef
8.
go back to reference Forés R, Alzamora MT, Pera G, Baena-Díez JM, Mundet-Tuduri X, Torán P (2018) Contribution of the ankle-brachial index to improve the prediction of coronary risk: the ARTPER cohort. PLoS One 13:e0191283CrossRef Forés R, Alzamora MT, Pera G, Baena-Díez JM, Mundet-Tuduri X, Torán P (2018) Contribution of the ankle-brachial index to improve the prediction of coronary risk: the ARTPER cohort. PLoS One 13:e0191283CrossRef
9.
go back to reference Velescu A, Clara A, Peñafiel J, Ramos R, Marti R, Grau M, Dégano IR, Marrugat J, Elosua R, REGICOR Study Group (2015) Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events. The REGICOR study. Atherosclerosis 241:357–363CrossRef Velescu A, Clara A, Peñafiel J, Ramos R, Marti R, Grau M, Dégano IR, Marrugat J, Elosua R, REGICOR Study Group (2015) Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events. The REGICOR study. Atherosclerosis 241:357–363CrossRef
10.
go back to reference Agarwal SK, Kasula S, Hacioglu Y, Ahmed Z, Uretsky BF, Hakeem A (2016) Utilizing Post-intervention fractional flow reserve to optimize acute results and the relationship to long-term outcomes. JACC Cardiovasc Interv 9:1022–1031CrossRef Agarwal SK, Kasula S, Hacioglu Y, Ahmed Z, Uretsky BF, Hakeem A (2016) Utilizing Post-intervention fractional flow reserve to optimize acute results and the relationship to long-term outcomes. JACC Cardiovasc Interv 9:1022–1031CrossRef
11.
go back to reference McDermott MM, Kibbe M, Guralnik JM, Pearce WH, Tian L, Liao Y, Zhao L, Criqui MH (2013) Comparative effectiveness study of self-directed walking exercise, lower extremity revascularization, and functional decline in peripheral artery disease. J Vasc Surg 57:990.e1–996.e1CrossRef McDermott MM, Kibbe M, Guralnik JM, Pearce WH, Tian L, Liao Y, Zhao L, Criqui MH (2013) Comparative effectiveness study of self-directed walking exercise, lower extremity revascularization, and functional decline in peripheral artery disease. J Vasc Surg 57:990.e1–996.e1CrossRef
12.
go back to reference Je HG, Kim BH, Cho KI, Jang JS, Park YH, Spertus J (2015) Correlation between patient-reported symptoms and ankle-brachial index after revascularization for peripheral arterial disease. Int J Mol Sci 16:11355–11368CrossRef Je HG, Kim BH, Cho KI, Jang JS, Park YH, Spertus J (2015) Correlation between patient-reported symptoms and ankle-brachial index after revascularization for peripheral arterial disease. Int J Mol Sci 16:11355–11368CrossRef
13.
go back to reference Stoner MC, Calligaro KD, Chaer RA, Dietzek AM, Farber A, Guzman RJ, Hamdan AD, Landry GJ, Yamaguchi DJ, Society for Vascular Surgery (2016) Reporting standards of the society for vascular surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg 64:e1–e21CrossRef Stoner MC, Calligaro KD, Chaer RA, Dietzek AM, Farber A, Guzman RJ, Hamdan AD, Landry GJ, Yamaguchi DJ, Society for Vascular Surgery (2016) Reporting standards of the society for vascular surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg 64:e1–e21CrossRef
14.
go back to reference Reed GW, Young L, Bagh I, Maier M, Shishehbor MH (2017) Hemodynamic assessment before and after endovascular therapy for critical limb ischemia and association with clinical outcomes. JACC Cardiovasc Interv 10:2451–2457CrossRef Reed GW, Young L, Bagh I, Maier M, Shishehbor MH (2017) Hemodynamic assessment before and after endovascular therapy for critical limb ischemia and association with clinical outcomes. JACC Cardiovasc Interv 10:2451–2457CrossRef
15.
go back to reference Sukul D, Grey SF, Henke PK, Gurm HS, Grossman PM (2017) Heterogeneity of ankle-brachial indices in patients undergoing revascularization for critical limb ischemia. JACC Cardiovasc Interv 10:2307–2316CrossRef Sukul D, Grey SF, Henke PK, Gurm HS, Grossman PM (2017) Heterogeneity of ankle-brachial indices in patients undergoing revascularization for critical limb ischemia. JACC Cardiovasc Interv 10:2307–2316CrossRef
16.
go back to reference Hong S-J, Ko Y-G, Shin D-H, Kim J-S, Kim B-K, Choi D, Hong M-K, Jang Y (2015) Outcomes of spot stenting versus long stenting after intentional subintimal approach for long chronic total occlusions of the femoropopliteal artery. JACC Cardiovasc Interv 8:472–480CrossRef Hong S-J, Ko Y-G, Shin D-H, Kim J-S, Kim B-K, Choi D, Hong M-K, Jang Y (2015) Outcomes of spot stenting versus long stenting after intentional subintimal approach for long chronic total occlusions of the femoropopliteal artery. JACC Cardiovasc Interv 8:472–480CrossRef
17.
go back to reference Soga Y, Iida O, Kawasaki D, Yamauchi Y, Suzuki K, Hirano K, Koshida R, Kamoi D, Tazaki J, Higashitani M, Shintani Y, Yamaoka T, Okazaki S, Suematsu N, Tsuchiya T, Miyashita Y, Shinozaki N, Takahashi H, on behalf of REAL-AI investigators (2012) Contemporary outcomes after endovascular treatment for aorto–iliac artery disease. Circ J 76:2697–2704CrossRef Soga Y, Iida O, Kawasaki D, Yamauchi Y, Suzuki K, Hirano K, Koshida R, Kamoi D, Tazaki J, Higashitani M, Shintani Y, Yamaoka T, Okazaki S, Suematsu N, Tsuchiya T, Miyashita Y, Shinozaki N, Takahashi H, on behalf of REAL-AI investigators (2012) Contemporary outcomes after endovascular treatment for aorto–iliac artery disease. Circ J 76:2697–2704CrossRef
18.
go back to reference Soga Y, Iida O, Hirano K, Yokoi H, Nanto S, Nobuyoshi M (2010) Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. J Vasc Surg 52:608–615CrossRef Soga Y, Iida O, Hirano K, Yokoi H, Nanto S, Nobuyoshi M (2010) Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. J Vasc Surg 52:608–615CrossRef
19.
go back to reference Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, Hiatt WR, Ho M, Ikeda K, Ikeno F, Jaff MR, Jones WS, Kawahara M, Lookstein RA, Mehran R, Misra S, Norgren L, Olin JW, Povsic TJ, Rosenfield K, Rundback J, Shamoun F, Tcheng J, Tsai TT, Suzuki Y, Vranckx P, Wiechmann BN, White CJ, Yokoi H, Krucoff MW (2015) Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol 65:931–941CrossRef Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, Hiatt WR, Ho M, Ikeda K, Ikeno F, Jaff MR, Jones WS, Kawahara M, Lookstein RA, Mehran R, Misra S, Norgren L, Olin JW, Povsic TJ, Rosenfield K, Rundback J, Shamoun F, Tcheng J, Tsai TT, Suzuki Y, Vranckx P, Wiechmann BN, White CJ, Yokoi H, Krucoff MW (2015) Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol 65:931–941CrossRef
20.
go back to reference Soga Y, Takahara M, Iida O, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Yamaoka T, Ando K (2015) Relationship between primary patency and lesion length following bare nitinol stent placement for femoropopliteal disease. J Endovasc Ther 22:862–867CrossRef Soga Y, Takahara M, Iida O, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Yamaoka T, Ando K (2015) Relationship between primary patency and lesion length following bare nitinol stent placement for femoropopliteal disease. J Endovasc Ther 22:862–867CrossRef
21.
go back to reference Iida O, Soga Y, Hirano K, Suzuki K, Yokoi H, Nobuyoshi M, Muramatsu T, Inoue N, Nanto S, Uematsu M (2011) Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis. J Endovasc Ther 18:753–761CrossRef Iida O, Soga Y, Hirano K, Suzuki K, Yokoi H, Nobuyoshi M, Muramatsu T, Inoue N, Nanto S, Uematsu M (2011) Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis. J Endovasc Ther 18:753–761CrossRef
22.
go back to reference Meneveau N, Souteyrand G, Motreff P, Caussin C, Amabile N, Ohlmann P, Morel O, Lefrançois Y, Descotes-Genon V, Silvain J, Braik N, Chopard R, Chatot M, Ecarnot F, Tauzin H, Van Belle E, Belle L, Schiele F (2016) Optical coherence tomography to optimize results of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome: results of the multicenter, randomized DOCTORS study (does optical coherence tomography optimize results of s. Circulation 134:906–917CrossRef Meneveau N, Souteyrand G, Motreff P, Caussin C, Amabile N, Ohlmann P, Morel O, Lefrançois Y, Descotes-Genon V, Silvain J, Braik N, Chopard R, Chatot M, Ecarnot F, Tauzin H, Van Belle E, Belle L, Schiele F (2016) Optical coherence tomography to optimize results of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome: results of the multicenter, randomized DOCTORS study (does optical coherence tomography optimize results of s. Circulation 134:906–917CrossRef
23.
go back to reference Kokkinos P, Faselis C, Myers J, Sui X, Zhang J, Blair SN (2014) Age-specific exercise capacity threshold for mortality risk assessment in male veterans. Circulation 130:653–658CrossRef Kokkinos P, Faselis C, Myers J, Sui X, Zhang J, Blair SN (2014) Age-specific exercise capacity threshold for mortality risk assessment in male veterans. Circulation 130:653–658CrossRef
Metadata
Title
Clinical impact of improvement in the ankle–brachial index after endovascular therapy for peripheral arterial disease
Authors
Tomonori Katsuki
Kyohei Yamaji
Yusuke Tomoi
Seiichi Hiramori
Yoshimitsu Soga
Kenji Ando
Publication date
01-02-2020
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 2/2020
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-019-01485-z

Other articles of this Issue 2/2020

Heart and Vessels 2/2020 Go to the issue